Not long ago, only about five out of 100 people were expected to be alive 5 years after a diagnosis with an advanced form of lung cancer. Today, up to four times more live that long, thanks to treatments that help unleash the immune system to attack cancer.
The results are even more impressive for late-stage patients with melanoma, a type of skin cancer.
These so-called immune checkpoint blockades have revolutionized cancer care, putting immune therapy on par with chemotherapy, radiation, surgery, and targeted therapies as a cornerstone of treatment for many tumor types.
This article highlights the scope for developing therapeutics with new innovative, alternative approaches. The current trillion dollars pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention. The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways.
Watch this Video to understand how recent advances provide breakthrough technology for doing scalable modeling of complex molecular systems to dramatically accelerate drug discovery and development.